These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 15375535
1. Thymidylate synthase expression pattern is a prognostic factor in patients of colorectal cancer treated with 5-fluorouracil. Fernández-Contreras ME, Jiménez De Ayala B, García De Paredes ML, Velasco A, Majano PL, Palacios J, Gamallo C. Int J Oncol; 2004 Oct; 25(4):877-85. PubMed ID: 15375535 [Abstract] [Full Text] [Related]
2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C. Oncology; 2006 Oct; 70(5):366-77. PubMed ID: 17179731 [Abstract] [Full Text] [Related]
3. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer. Ladner RD, Lynch FJ, Groshen S, Xiong YP, Sherrod A, Caradonna SJ, Stoehlmacher J, Lenz HJ. Cancer Res; 2000 Jul 01; 60(13):3493-503. PubMed ID: 10910061 [Abstract] [Full Text] [Related]
4. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information. Ohrling K, Edler D, Hallström M, Ragnhammar P, Blomgren H. J Clin Oncol; 2005 Aug 20; 23(24):5628-34. PubMed ID: 16009948 [Abstract] [Full Text] [Related]
5. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil. Kornmann M, Schwabe W, Sander S, Kron M, Sträter J, Polat S, Kettner E, Weiser HF, Baumann W, Schramm H, Häusler P, Ott K, Behnke D, Staib L, Beger HG, Link KH. Clin Cancer Res; 2003 Sep 15; 9(11):4116-24. PubMed ID: 14519634 [Abstract] [Full Text] [Related]
6. Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment. Dotor E, Cuatrecases M, Martínez-Iniesta M, Navarro M, Vilardell F, Guinó E, Pareja L, Figueras A, Molleví DG, Serrano T, de Oca J, Peinado MA, Moreno V, Germà JR, Capellá G, Villanueva A. J Clin Oncol; 2006 Apr 01; 24(10):1603-11. PubMed ID: 16575011 [Abstract] [Full Text] [Related]
7. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer. Kim SH, Kwon HC, Oh SY, Lee DM, Lee S, Lee JH, Roh MS, Kim DC, Park KJ, Choi HJ, Kim HJ. Am J Clin Oncol; 2009 Feb 01; 32(1):38-43. PubMed ID: 19194123 [Abstract] [Full Text] [Related]
8. Thymidylate synthase expression pattern, expression level and single nucleotide polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with 5-fluorouracil. Fernández-Contreras ME, Sánchez-Prudencio S, Sánchez-Hernández JJ, García de Paredes ML, Gisbert JP, Roda-Navarro P, Gamallo C. Int J Oncol; 2006 May 01; 28(5):1303-10. PubMed ID: 16596248 [Abstract] [Full Text] [Related]
9. Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer. Hu YC, Komorowski RA, Graewin S, Hostetter G, Kallioniemi OP, Pitt HA, Ahrendt SA. Clin Cancer Res; 2003 Sep 15; 9(11):4165-71. PubMed ID: 14519641 [Abstract] [Full Text] [Related]
10. Intratumoural expression of thymidylate synthase is an independent predictor of prognosis in patients with squamous cell carcinoma of the tongue: results from a retrospective study. Kawano K, Yanagisawa S, Kusukawa J, Sunagawa H, Shiba R, Goto M, Shinohara M, Fukuda J, Oishi M, Ikemura K, Takahashi T, Sugihara K, Inokuchi T, Mimura T, Goto H. Int J Oral Maxillofac Surg; 2006 Mar 15; 35(3):258-64. PubMed ID: 16280240 [Abstract] [Full Text] [Related]
11. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy. Yamada H, Iinuma H, Watanabe T. Oncol Rep; 2008 Mar 15; 19(3):729-35. PubMed ID: 18288408 [Abstract] [Full Text] [Related]
12. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV, Leichman L. Cancer Res; 1995 Apr 01; 55(7):1407-12. PubMed ID: 7882343 [Abstract] [Full Text] [Related]
13. Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer. Aguiar S, Lopes A, Soares FA, Rossi BM, Ferreira FO, Nakagawa WT, Carvalho AL, Filho WJ. Eur J Surg Oncol; 2005 Oct 01; 31(8):863-8. PubMed ID: 15923105 [Abstract] [Full Text] [Related]
14. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy. Kamoshida S, Matsuoka H, Ishikawa T, Maeda K, Shimomura R, Inada K, Tsutsumi Y. Jpn J Clin Oncol; 2004 Oct 01; 34(10):594-601. PubMed ID: 15591457 [Abstract] [Full Text] [Related]
19. Thymidylate synthase expression as a predictor of the prognosis of curatively resected colon carcinoma in patients registered in an adjuvant immunochemotherapy clinical trial. Sakamoto J, Hamashima H, Suzuki H, Ito K, Mai M, Saji S, Fukushima M, Matsushita Y, Nakazato H. Oncol Rep; 2003 Oct 01; 10(5):1081-90. PubMed ID: 12883662 [Abstract] [Full Text] [Related]
20. Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma. Wong NA, Brett L, Stewart M, Leitch A, Longley DB, Dunlop MG, Johnston PG, Lessells AM, Jodrell DI. Br J Cancer; 2001 Dec 14; 85(12):1937-43. PubMed ID: 11747337 [Abstract] [Full Text] [Related] Page: [Next] [New Search]